Open AccessHistological outcome for chronic hepatitis B patients treated with entecavirvslamivudine-based therapy
Author(s) -
Jiali Wang,
Xihao Du,
Shao-Long Chen,
Yiqi Yu,
Jing Wang,
Xiaowen Hu,
Lingyun Shao,
Jia-Zhen Chen,
Xinhua Weng,
Wenhong Zhang
Publication year - 2015
Publication title -
world journal of gastroenterology
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 1.427
H-Index - 155
eISSN - 2219-2840
pISSN - 1007-9327
DOI - 10.3748/wjg.v21.i32.9598
Subject(s) - entecavir , medicine , gastroenterology , lamivudine , hbeag , cirrhosis , fibrosis , hepatitis b , exact test , mann–whitney u test , retrospective cohort study , hepatitis b virus , hbsag , immunology , virus
To compare the histological outcome of chronic hepatitis B (CHB) patients treated with entecavir (ETV) or lamivudine (LAM)-based therapy.